Adequate IVIG dosing is associated with an improved long-term outcome in secondary immunodeficiency: A&#160;prospective, non-interventional study.

Intratect (intravenous normal human immunoglobulin) - ADMA Biologics

http://www.ncbi.nlm.nih.gov/pubmed/39078054

Artur Bauhofer; Jörg Schüttrumpf; Monika Mayer; Sonja Schimo; Stephan Borte; Ümniye Balaban

Jul 30, 2024